Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,630 | -74,207 | -81,152 | -33,818 | -23,361 |
| Depreciation Amortization | 3,364 | 8,294 | 14,445 | 268 | 1,976 |
| Income taxes - deferred | -86 | -1,143 | -3,448 | -2,315 | N/A |
| Accounts receivable | 1,217 | -3,619 | -508 | 28 | -106 |
| Accounts payable and accrued liabilities | -992 | 1,629 | -810 | -223 | 1,140 |
| Other Working Capital | -46 | -1,406 | -142 | 1,201 | 1,891 |
| Other Operating Activity | 9,623 | 56,252 | 44,125 | 10,271 | -2,196 |
| Operating Cash Flow | $-8,550 | $-14,200 | $-27,490 | $-24,588 | $-20,656 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,390 | -2,014 | -10,328 | -137 | -14 |
| Net Acquisitions | N/A | N/A | N/A | -1,849 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -4,382 | 0 |
| Investing Cash Flow | $-2,390 | $-2,014 | $-10,328 | $-6,368 | $-14 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 9,500 | N/A | N/A | N/A | 17,250 |
| Debt Issued | 955 | 2,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -2,200 | N/A | N/A | N/A |
| Common Stock Issued | 679 | 13,924 | 38,258 | 42,333 | 5 |
| Other Financing Activity | -59 | -65 | -5,055 | -4,525 | -1,202 |
| Financing Cash Flow | $11,075 | $13,659 | $33,203 | $37,808 | $16,053 |
| Exchange Rate Effect | -113 | -8 | N/A | N/A | N/A |
| Beginning Cash Position | 2,985 | 5,548 | 10,163 | 3,311 | 7,927 |
| End Cash Position | 3,007 | 2,985 | 5,548 | 10,163 | 3,311 |
| Net Cash Flow | $22 | $-2,563 | $-4,615 | $6,852 | $-4,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,550 | -14,200 | -27,490 | -24,588 | -20,656 |
| Capital Expenditure | -2,390 | -2,014 | -10,328 | -137 | -14 |
| Free Cash Flow | -10,940 | -16,214 | -37,818 | -24,725 | -20,670 |